Shares

8 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2022

Aug 09, 2022

BUY
$7.38 - $10.4 $15,446 - $21,767
2,093 New
2,093 $16,000
Q2 2019

Jul 19, 2019

SELL
$8.12 - $15.72 $58,610 - $113,466
-7,218 Closed
0 $0
Q1 2019

May 10, 2019

SELL
$15.58 - $20.01 $80,237 - $103,051
-5,150 Reduced 41.64%
7,218 $113,000
Q4 2018

Feb 13, 2019

SELL
$14.59 - $23.84 $339,655 - $554,995
-23,280 Reduced 65.31%
12,368 $191,000
Q3 2018

Nov 14, 2018

BUY
$21.06 - $25.65 $15,268 - $18,596
725 Added 2.08%
35,648 $768,000
Q2 2018

Aug 03, 2018

BUY
$16.77 - $24.71 $288,527 - $425,135
17,205 Added 97.1%
34,923 $849,000
Q1 2018

Apr 20, 2018

BUY
$16.68 - $22.07 $10,008 - $13,242
600 Added 3.51%
17,718 $303,000
Q4 2017

Feb 02, 2018

BUY
$11.23 - $19.1 $192,235 - $326,953
17,118
17,118 $324,000

Others Institutions Holding TEVA

About TEVA PHARMACEUTICAL INDUSTRIES LTD


  • Ticker TEVA
  • Exchange OTC
  • Sector Healthcare
  • Industry Drug Manufacturers—Specialty & Generic
  • Shares Outstandng 1,110,560,000
  • Market Cap $19.4B
  • Description
  • Teva Pharmaceutical Industries Limited, a pharmaceutical company, develops, manufactures, markets, and distributes generic medicines, specialty medicines, and biopharmaceutical products in North America, Europe, and internationally. The company offers sterile products, hormones, high-potency drugs, and cytotoxic substances in various dosage form...
More about TEVA
Track This Portfolio

Track Sea Crest Wealth Management, LLC Portfolio

Follow Sea Crest Wealth Management, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Sea Crest Wealth Management, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Sea Crest Wealth Management, LLC with notifications on news.